Iveric Bio Inc 's

• ISEE's Stock Performance relative to its Competitors

Deciphera Pharmaceuticals Inc Share Performance +82.52% One Year

Deciphera Pharmaceuticals Inc Profile Deciphera Pharmaceuticals Inc's business model revolves around the research, development, and commercialization of precision medicines for the treatment of cancer and other serious diseases. More about Deciphera Pharmaceuticals Inc 's Market Share

Nuvalent Inc Share Performance +22.93% This Year

Nuvalent Inc Profile Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise. More about Nuvalent Inc 's Market Share

Rhythm Pharmaceuticals Inc Share Performance -6.67% This Year

Rhythm Pharmaceuticals Inc Profile Rhythm Pharmaceuticals Inc's business model focuses on developing and commercializing therapies for rare genetic disorders that result in unmet medical needs. More about Rhythm Pharmaceuticals Inc 's Market Share

Chinook Therapeutics Inc Share Performance +58.77% This Year

Chinook Therapeutics Inc Profile Chinook Therapeutics is a biotechnology company focused on the development of precision medicines for kidney diseases and other rare disorders. Their business model revolves around identifying and targeting specific pathways involved in the progression of kidney diseases, leveraging innovative technologies and partnerships to develop novel therapies that can improve patient outcomes. By prioritizing the unmet needs in the field of kidney diseases, Chinook aims to deliver transformative treatments to patients while creating value for their stakeholders. More about Chinook Therapeutics Inc 's Market Share

Praxis Precision Medicines Inc Share Performance +7.89% This Year

Praxis Precision Medicines Inc Profile Praxis Precision Medicines Inc's business model revolves around developing precision medicines for the treatment of various central nervous system (CNS) disorders. More about Praxis Precision Medicines Inc 's Market Share

Sources: Iveric Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 15, 2026 7:24 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Iveric Bio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.